Article Details
Retrieved on: 2022-03-29 06:19:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Nyrada (ASX:NYR) says its new brain injury drug candidate NYR-BI02 has shown "excellent oral bioavailability" and will be put to the test in a ...
Article found on: themarketherald.com.au
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here